These data suggest possible effects of glioma on FAP expression in distal tissues, and more consideration needs to be given to the use of FAP as a diagnostic biomarker and side effects of FAP as a therapeutic target in clinical practice. The gene discussed is FAP; the disease is central nervous system cancer.